Neurocrine Biosciences shares owned by Parkman Healthcare Partners
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Parkman Healthcare Partners
from 13F filings
Historical chart of Parkman Healthcare Partners investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Parkman Healthcare Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $9.4M | 84k | 112.50 |
| 2023-06-30 | $13M | 140k | 94.30 |
| 2023-03-31 | $22M | 218k | 101.22 |
| 2022-12-31 | $14M | 116k | 119.44 |
| 2022-09-30 | $13M | 117k | 106.21 |
| 2022-06-30 | $8.3M | 86k | 97.48 |
| 2022-03-31 | $5.9M | 63k | 93.75 |
| 2020-09-30 | $13M | 133k | 96.16 |
| 2020-06-30 | $15M | 122k | 122.00 |
| 2020-03-31 | $11M | 129k | 86.55 |
| 2019-12-31 | $17M | 155k | 107.49 |
More positions owned by Parkman Healthcare Partners
View all positions for Parkman Healthcare Partners